Gold slumped more than 5 per cent on Monday as news of the first successful late-stage Covid-19 vaccine trials prompted investors to dump safe-haven bullion and flock to riskier assets.
Spot gold was down 5.1 per cent at $1,852.82 per ounce by 11:07 a.m. EDT (1607 GMT), while U.S. gold futures slid 4.9 per cent to $1,855.30.
Spot prices beat a sharp retreat from a near two-month peak of $1,965.33 hit earlier in the session amid a weaker dollar and hopes for more stimulus following Joe Biden's victory in the U.S. elections.
Equities surged after Pfizer Inc said its experimental Covid-19 vaccine was